Article
Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.
Journal of clinical psychopharmacology - 1 Oct 2011
Yasui-Furukori Norio, Tsuchimine Shoko, Saito Manabu, Nakagami Taku, Sugawara Norio, Fujii Akira, Kaneko Sunao
Abstract excerpt
Although several studies have reported that dopamine D₂ receptor (DRD2) polymorphisms affect the therapeutic efficacy of antipsychotics, other studies have suggested that the plasma drug concentration is related to the clinical response. Currently, there are no definitive data regarding which factor has greater clinical significance. Sixty patients with acute exacerbations of schizophrenia received 6 mg/d of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
